Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0511 Transporter Info | ||||
Gene Name | KCNJ11 | ||||
Transporter Name | ATP-sensitive inward rectifier potassium channel 11 | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview ofKCNJ11 Modification Sites with Functional and Structural Information | |||||
Sequence | MLSRKGIIPE EYVLTRLAED PAEPRYRARQ RRARFVSKKG NCNVAHKNIR EQGRFLQDVF
TTLVDLKWPH TLLIFTMSFL CSWLLFAMAW WLIAFAHGDL APSEGTAEPC VTSIHSFSSA FLFSIEVQVT IGFGGRMVTE ECPLAILILI VQNIVGLMIN AIMLGCIFMK TAQAHRRAET LIFSKHAVIA LRHGRLCFML RVGDLRKSMI ISATIHMQVV RKTTSPEGEV VPLHQVDIPM ENGVGGNSIF LVAPLIIYHV IDANSPLYDL APSDLHHHQD LEIIVILEGV VETTGITTQA RTSYLADEIL WGQRFVPIVA EEDGRYSVDY SKFGNTIKVP TPLCTARQLD EDHSLLEALT LASARGPLRK RSVPMAKAKP KFSISPDSLS |
||||
PTM type |
X-Oxidation
X-Phosphorylation
X-Phosphorylation
X-Ubiquitination
X: Amino Acid
|
Oxidation |
|||||
---|---|---|---|---|---|
Cystine | 2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence KCNJ11 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
42 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Oxidation at KCNJ11 Cystine 42 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence KCNJ11 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
344 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Oxidation at KCNJ11 Cystine 344 has the potential to affect its expression or activity. | ||||
Phosphorylation |
|||||
Serine | 6 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence KCNJ11 | [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
184 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 Serine 184 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
. | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
208 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 Serine 208 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
. | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
285 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 Serine 285 has the potential to affect its expression or activity. | ||||
PTM Phenomenon4 |
Have the potential to influence KCNJ11 | [2], [5] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
372 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 Serine 372 has the potential to affect its expression or activity. | ||||
PTM Phenomenon5 |
Have the potential to influence KCNJ11 | [6], [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
385 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 Serine 385 has the potential to affect its expression or activity. | ||||
PTM Phenomenon6 |
Have the potential to influence KCNJ11 | [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
388 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 Serine 388 has the potential to affect its expression or activity. | ||||
Threonine | 8 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
. | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
93 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 Threonine 93 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
. | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
137 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 Threonine 137 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
. | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
137 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 Threonine 137 has the potential to affect its expression or activity. | ||||
PTM Phenomenon4 |
. | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
137 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 Threonine 137 has the potential to affect its expression or activity. | ||||
PTM Phenomenon5 |
. | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
180 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 Threonine 180 has the potential to affect its expression or activity. | ||||
PTM Phenomenon6 |
. | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
224 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 Threonine 224 has the potential to affect its expression or activity. | ||||
PTM Phenomenon7 |
Have the potential to influence KCNJ11 | [9] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
298 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 Threonine 298 has the potential to affect its expression or activity. | ||||
PTM Phenomenon8 |
Have the potential to influence KCNJ11 | [6], [9] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
341 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 Threonine 341 has the potential to affect its expression or activity. | ||||
Tyrosine | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence KCNJ11 | [10] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
26 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 Tyrosine 26 has the potential to affect its expression or activity. | ||||
Unclear Residue | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Affecting the stability and reducing the activity of KCNJ11 | [9] | |||
Role of PTM |
Protein Stability | ||||
Related Enzyme |
|||||
Experimental Material(s) |
Human embryonic kidney 293 (HEK293) cells | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at KCNJ11 have been reported to affect its stability and reduce its transport activity. | ||||
Ubiquitination |
|||||
Lysine | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence KCNJ11 | [11] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
332 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at KCNJ11 Lysine 332 has the potential to affect its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.